Advanz Pharma Corp. buy melinda
Start price
15.08.17
/
50%
€384.00
Target price
19.12.17
€450.00
Performance (%)
-45.31%
End price
19.12.17
€210.00
Summary
This prediction ended on 19.12.17 with a price of €210.00. Massive losses of -45.31% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Advanz Pharma Corp. | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by melinda for this prediction
In the thread Advanz Pharma Corp diskutieren
(Vom Mitglied beendet)
Stopped prediction by melinda for Advanz Pharma Corp.
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€346.37
15.08.17
15.08.17
€405.90
19.12.17
19.12.17
-45.31%
19.12.17
19.12.17
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€2,570.4
12.08.16
12.08.16
€3,264.0
13.02.17
13.02.17
-74.52%
13.02.17
13.02.17